ProQR Therapeutics N.V. (PRQR) vs Yarrow Bioscience Inc (YARW)
A side-by-side comparison of ProQR Therapeutics N.V. and Yarrow Bioscience Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
PRQR
ProQR Therapeutics N.V.
$1.65HealthcareDelayed quote: Oct 6, 2026, 1:49 PM EDT
YARW
Yarrow Bioscience Inc
$19.17HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
Total return — PRQR vs YARW
growth of $100 · dividends reinvested · last 9yPRQR -45.2% (-6.5%/yr)YARW -100.0% (-58.7%/yr)PRQR compounded faster over this window
Log scale — wide-divergence pair
PRQR YARW
PRQR vs YARW: by the numbers
- •YARW is the larger company ($178M vs $174M market cap).
- •Both run net losses; PRQR's is the smaller (-229.20% vs -3881.54% net margin).
- •PRQR grew revenue faster over the past five years (94.34% vs -43.10% CAGR).
- •YARW pays a dividend (105.68% yield), while PRQR has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | PRQR | YARW |
|---|---|---|
| P/S ratio | 8.09 | 370.05 |
| P/B ratio | 1.91 | 8.08 |
Profitability
| Metric | PRQR | YARW |
|---|---|---|
| Gross margin | 83.01% | 97.51% |
| Operating margin | -275.91% | -5219.12% |
| Net margin | -229.20% | -3881.54% |
| ROE | -54.27% | -84.80% |
| ROIC | -42.61% | -90.33% |
Dividends
| Metric | PRQR | YARW |
|---|---|---|
| Dividend yield | N/A | 105.68% |
Growth (annualized)
| Metric | PRQR | YARW |
|---|---|---|
| Revenue CAGR (5Y) | 94.34% | -43.10% |
| Total return CAGR (5Y) | -26.23% | -49.18% |
Frequently asked
- Which has grown faster, PRQR or YARW?
- Over the past five years, PRQR grew revenue faster — PRQR at a 94.34% CAGR versus YARW at -43.10%.
- Does PRQR or YARW pay a bigger dividend?
- YARW pays a dividend (105.68% yield), while PRQR has no payments in the available dividend history.
- How have PRQR and YARW total returns compared?
- Over the past 5 years, PRQR delivered -26.23% and YARW delivered -49.18% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Yarrow Bioscience dividend yieldProQR Therapeutics ROEYarrow Bioscience ROEProQR Therapeutics operating marginYarrow Bioscience operating marginProQR Therapeutics revenue growthYarrow Bioscience revenue growthProQR Therapeutics free cash flowYarrow Bioscience free cash flow
ProQR Therapeutics & Yarrow Bioscience appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.